|
2014-12-08 |
2014-12-05 |
S
Sale
|
Lurker Nancy
Non-Executive Director
|
7,430
-42.6%
34.00
USD 252,620
|
7,430
-42.6%
|
34.00
|
USD 252,620
|
|
|
2014-12-08 |
2014-12-05 |
S
Sale
|
Lurker Nancy
Non-Executive Director
|
25,000
-58.9%
34.00
USD 850,000
|
25,000
-58.9%
|
34.00
|
USD 850,000
|
|
|
2014-12-08 |
2014-12-05 |
S
Sale
|
MCKEE WILLIAM
Non-Executive Director
|
18,000
-64.3%
34.00
USD 612,000
|
18,000
-64.3%
|
34.00
|
USD 612,000
|
|
|
2014-12-08 |
2014-12-05 |
S
Sale
|
ADAMS ADRIAN
CEO and President
Executive Director
|
40,000
-15.5%
33.97
USD 1,358,704
|
40,000
-15.5%
|
33.97
|
USD 1,358,704
|
|
|
2014-12-08 |
2014-12-05 |
S
Sale
|
FRIEDMAN PAUL A
Non-Executive Director
|
9,689
-48.3%
33.85
USD 327,953
|
9,689
-48.3%
|
33.85
|
USD 327,953
|
|
|
2014-12-08 |
2014-12-04 |
S
Sale
|
FRIEDMAN PAUL A
Non-Executive Director
|
20,000
-49.9%
33.67
USD 673,452
|
20,000
-49.9%
|
33.67
|
USD 673,452
|
|
|
2014-12-04 |
2014-12-03 |
S
Sale
|
FETZER OLIVER
Non-Executive Director
|
50,000
-72.3%
34.00
USD 1,700,000
|
50,000
-72.3%
|
34.00
|
USD 1,700,000
|
|
|
2014-12-04 |
2014-12-02 |
S
Sale
|
CLASSON ROLF A
Non-Executive Director
|
19,135
-65.7%
33.75
USD 645,726
|
19,135
-65.7%
|
33.75
|
USD 645,726
|
|
|
2014-12-04 |
2014-12-02 |
S
Sale
|
CLASSON ROLF A
Non-Executive Director
|
260,000
-89.9%
33.81
USD 8,790,808
|
260,000
-89.9%
|
33.81
|
USD 8,790,808
|
|
|
2014-12-04 |
2014-12-02 |
S
Sale
|
FETZER OLIVER
Non-Executive Director
|
50,000
-72.3%
34.03
USD 1,701,635
|
50,000
-72.3%
|
34.03
|
USD 1,701,635
|
|
|
2014-11-26 |
2014-11-25 |
S
Sale
|
JOBES ELIZABETH VARKI
Chief Compliance Officer
Officer
|
23,750
-63.3%
34.03
USD 808,310
|
23,750
-63.3%
|
34.03
|
USD 808,310
|
|
|
2014-11-26 |
2014-11-25 |
S
Sale
|
JOBES ELIZABETH VARKI
Chief Compliance Officer
Officer
|
4,052
-9.7%
34.05
USD 137,964
|
4,052
-9.7%
|
34.05
|
USD 137,964
|
|
|
2014-11-26 |
2014-11-25 |
S
Sale
|
Tursi James Patrick
Chief Medical Officer
Officer
|
3,151
-9.0%
34.13
USD 107,534
|
3,151
-9.0%
|
34.13
|
USD 107,534
|
|
|
2014-11-26 |
2014-11-25 |
S
Sale
|
Tursi James Patrick
Chief Medical Officer
Officer
|
10,562
-23.2%
34.12
USD 360,394
|
10,562
-23.2%
|
34.12
|
USD 360,394
|
|
|
2014-11-24 |
2014-11-21 |
S
Sale
|
KOVEN ANDREW I
EVP, CAO, GC and Secretary
Officer
|
134,375
-77.6%
33.43
USD 4,492,412
|
134,375
-77.6%
|
33.43
|
USD 4,492,412
|
|
|
2014-11-24 |
2014-11-21 |
S
Sale
|
KOVEN ANDREW I
EVP, CAO, GC and Secretary
Officer
|
5,308
-3.0%
33.44
USD 177,518
|
5,308
-3.0%
|
33.44
|
USD 177,518
|
|
|
2014-11-24 |
2014-11-21 |
S
Sale
|
Armstrong Jennifer Lou
Senior Vice President, HR
Officer
|
69,412
-82.4%
33.50
USD 2,325,031
|
69,412
-82.4%
|
33.50
|
USD 2,325,031
|
|
|
2014-11-24 |
2014-11-21 |
S
Sale
|
Armstrong Jennifer Lou
Senior Vice President, HR
Officer
|
6,391
-7.0%
33.50
USD 214,075
|
6,391
-7.0%
|
33.50
|
USD 214,075
|
|
|
2014-11-24 |
2014-11-21 |
S
Sale
|
Tursi James Patrick
Chief Medical Officer
Officer
|
5,000
-12.5%
33.49
USD 167,432
|
5,000
-12.5%
|
33.49
|
USD 167,432
|
|
|
2014-11-24 |
2014-11-21 |
S
Sale
|
Tursi James Patrick
Chief Medical Officer
Officer
|
3,648
-8.3%
33.45
USD 122,011
|
3,648
-8.3%
|
33.45
|
USD 122,011
|
|
|
2014-11-24 |
2014-11-20 |
S
Sale
|
WILLS ALAN
EVP, Corporate Development
Officer
|
13,717
-30.9%
33.18
USD 455,086
|
13,717
-30.9%
|
33.18
|
USD 455,086
|
|
|
2014-11-24 |
2014-11-20 |
S
Sale
|
WILLS ALAN
EVP, Corporate Development
Officer
|
142,875
-76.3%
33.18
USD 4,740,207
|
142,875
-76.3%
|
33.18
|
USD 4,740,207
|
|
|
2014-11-24 |
2014-11-20 |
S
Sale
|
Glickman Mark A
EVP - Sales and Marketing
Officer
|
40,750
-59.3%
33.16
USD 1,351,372
|
40,750
-59.3%
|
33.16
|
USD 1,351,372
|
|
|
2014-11-24 |
2014-11-20 |
S
Sale
|
Glickman Mark A
EVP - Sales and Marketing
Officer
|
7,202
-9.5%
33.18
USD 238,963
|
7,202
-9.5%
|
33.18
|
USD 238,963
|
|
|
2014-11-24 |
2014-11-20 |
S
Sale
|
Tursi James Patrick
Chief Medical Officer
Officer
|
59,800
-57.8%
33.18
USD 1,983,871
|
59,800
-57.8%
|
33.18
|
USD 1,983,871
|
|
|
2014-11-24 |
2014-11-20 |
S
Sale
|
Tursi James Patrick
Chief Medical Officer
Officer
|
6,200
-5.7%
32.94
USD 204,253
|
6,200
-5.7%
|
32.94
|
USD 204,253
|
|
|
2014-03-17 |
2014-03-14 |
S
Sale
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Officer
|
524
-8.3%
29.55
USD 15,484
|
524
-8.3%
|
29.55
|
USD 15,484
|
|
|
2014-03-17 |
2014-03-14 |
S
Sale
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Officer
|
883
-12.3%
29.55
USD 26,093
|
883
-12.3%
|
29.55
|
USD 26,093
|
|
|
2014-03-17 |
2014-03-14 |
S
Sale
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Officer
|
30,625
-57.4%
29.50
USD 903,438
|
30,625
-57.4%
|
29.50
|
USD 903,438
|
|
|
2014-03-06 |
2014-03-05 |
S
Sale
|
CLASSON ROLF A
Non-Executive Director
|
10,000
-30.4%
31.85
USD 318,477
|
10,000
-30.4%
|
31.85
|
USD 318,477
|
|
|
2013-12-16 |
2013-12-13 |
PS
Planned sale
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Officer
|
302
-6.9%
20.50
USD 6,191
|
302
-6.9%
|
20.50
|
USD 6,191
|
|
|
2013-12-16 |
2013-12-13 |
S
Sale
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Officer
|
4,300
-49.6%
20.50
USD 88,150
|
4,300
-49.6%
|
20.50
|
USD 88,150
|
|
|
2013-12-12 |
2013-12-11 |
PS
Planned sale
|
Fickenscher James E
Chief Financial Officer
Officer
|
71,067
-61.2%
20.37
USD 1,447,450
|
71,067
-61.2%
|
20.37
|
USD 1,447,450
|
|
|
2013-05-22 |
2013-05-20 |
S
Sale
|
MCKEE WILLIAM
Non-Executive Director
|
2,000
-20.0%
15.10
USD 30,209
|
2,000
-20.0%
|
15.10
|
USD 30,209
|
|
|
2012-06-26 |
2012-06-25 |
PS
Planned sale
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Officer
|
12,682
-73.9%
25.01
USD 317,155
|
12,682
-73.9%
|
25.01
|
USD 317,155
|
|
|
2012-06-08 |
2012-06-06 |
S
Sale
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Officer
|
5,700
-73.8%
22.55
USD 128,536
|
5,700
-73.8%
|
22.55
|
USD 128,536
|
|
|
2012-06-08 |
2012-06-06 |
S
Sale
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Officer
|
300
-3.7%
22.55
USD 6,766
|
300
-3.7%
|
22.55
|
USD 6,766
|
|
|
2012-03-01 |
2012-02-28 |
B
Purchase
|
Brandt Peter C.
Non-Executive Director
|
9,700
+3233.3%
20.10
USD 194,970
|
9,700
+3233.3%
|
20.10
|
USD 194,970
|
|
|
2012-03-01 |
2012-02-28 |
B
Purchase
|
Brandt Peter C.
Non-Executive Director
|
300
+inf%
20.09
USD 6,028
|
300
+inf%
|
20.09
|
USD 6,028
|
|
|
2011-11-07 |
2011-11-03 |
B
Purchase
|
Fickenscher James E
Chief Financial Officer
Officer
|
1,610
+6.4%
15.54
USD 25,024
|
1,610
+6.4%
|
15.54
|
USD 25,024
|
|
|
2011-10-11 |
2011-10-07 |
PS
Planned sale
|
ANIDO ARMANDO
CEO & President
Executive Director
|
5,275
-27.9%
14.23
USD 75,046
|
5,275
-27.9%
|
14.23
|
USD 75,046
|
|
|
2011-08-03 |
2011-08-02 |
S
Sale
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
40,781
-0.7%
17.25
USD 703,391
|
40,781
-0.7%
|
17.25
|
USD 703,391
|
|
|
2011-08-03 |
2011-08-02 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
1,001
-0.7%
17.25
USD 17,265
|
1,001
-0.7%
|
17.25
|
USD 17,265
|
|
|
2011-08-03 |
2011-08-02 |
S
Sale
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
507
-0.7%
17.25
USD 8,745
|
507
-0.7%
|
17.25
|
USD 8,745
|
|
|
2011-08-03 |
2011-08-02 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
6,361
-0.7%
17.25
USD 109,715
|
6,361
-0.7%
|
17.25
|
USD 109,715
|
|
|
2011-08-03 |
2011-08-01 |
S
Sale
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
394,404
-6.7%
18.04
USD 7,114,614
|
394,404
-6.7%
|
18.04
|
USD 7,114,614
|
|
|
2011-08-03 |
2011-08-01 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
9,678
-6.7%
18.04
USD 174,580
|
9,678
-6.7%
|
18.04
|
USD 174,580
|
|
|
2011-08-03 |
2011-08-01 |
S
Sale
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
4,902
-6.7%
18.04
USD 88,427
|
4,902
-6.7%
|
18.04
|
USD 88,427
|
|
|
2011-08-03 |
2011-08-01 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
61,519
-6.7%
18.04
USD 1,109,735
|
61,519
-6.7%
|
18.04
|
USD 1,109,735
|
|
|
2011-08-03 |
2011-08-01 |
S
Sale
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
260,868
-4.3%
18.03
USD 4,703,320
|
260,868
-4.3%
|
18.03
|
USD 4,703,320
|
|
|
2011-08-03 |
2011-08-01 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
6,400
-4.3%
18.03
USD 115,389
|
6,400
-4.3%
|
18.03
|
USD 115,389
|
|
|
2011-08-03 |
2011-08-01 |
S
Sale
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
3,243
-4.3%
18.03
USD 58,470
|
3,243
-4.3%
|
18.03
|
USD 58,470
|
|
|
2011-08-03 |
2011-08-01 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
40,690
-4.3%
18.03
USD 733,620
|
40,690
-4.3%
|
18.03
|
USD 733,620
|
|
|
2011-07-12 |
2011-07-08 |
PS
Planned sale
|
ANIDO ARMANDO
CEO & President
Executive Director
|
5,275
-27.9%
20.30
USD 107,101
|
5,275
-27.9%
|
20.30
|
USD 107,101
|
|
|
2011-03-31 |
2011-03-30 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
3,911
+2.7%
21.98
USD 85,963
|
3,911
+2.7%
|
21.98
|
USD 85,963
|
|
|
2011-03-31 |
2011-03-30 |
B
Purchase
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
309
+4.6%
21.98
USD 6,792
|
309
+4.6%
|
21.98
|
USD 6,792
|
|
|
2011-03-31 |
2011-03-29 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
82,000
+1.4%
21.94
USD 1,798,670
|
82,000
+1.4%
|
21.94
|
USD 1,798,670
|
|
|
2011-03-31 |
2011-03-29 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
250,000
+4.3%
22.00
USD 5,499,400
|
250,000
+4.3%
|
22.00
|
USD 5,499,400
|
|
|
2011-03-10 |
2011-03-09 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
550,000
+10.5%
22.75
USD 12,513,765
|
550,000
+10.5%
|
22.75
|
USD 12,513,765
|
|
|
2011-03-10 |
2011-03-09 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
115,000
+2.3%
23.44
USD 2,695,060
|
115,000
+2.3%
|
23.44
|
USD 2,695,060
|
|
|
2011-03-10 |
2011-03-09 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
117,273
+2.3%
23.17
USD 2,717,344
|
117,273
+2.3%
|
23.17
|
USD 2,717,344
|
|
|
2011-03-10 |
2011-03-08 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
58,388
+1.2%
22.81
USD 1,331,976
|
58,388
+1.2%
|
22.81
|
USD 1,331,976
|
|
|
2011-03-10 |
2011-03-08 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
1,948
+0.0%
22.51
USD 43,845
|
1,948
+0.0%
|
22.51
|
USD 43,845
|
|
|
2011-03-10 |
2011-03-08 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
48,657
+1.0%
22.86
USD 1,112,299
|
48,657
+1.0%
|
22.86
|
USD 1,112,299
|
|
|
2011-03-10 |
2011-03-08 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
86,227
+1.8%
22.88
USD 1,972,693
|
86,227
+1.8%
|
22.88
|
USD 1,972,693
|
|
|
2011-03-10 |
2011-03-08 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
1,612
+1.1%
22.81
USD 36,774
|
1,612
+1.1%
|
22.81
|
USD 36,774
|
|
|
2011-03-10 |
2011-03-08 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
54
+0.0%
22.51
USD 1,215
|
54
+0.0%
|
22.51
|
USD 1,215
|
|
|
2011-03-10 |
2011-03-08 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
1,343
+0.9%
22.86
USD 30,701
|
1,343
+0.9%
|
22.86
|
USD 30,701
|
|
|
2011-03-10 |
2011-03-08 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
2,380
+1.7%
22.88
USD 54,449
|
2,380
+1.7%
|
22.88
|
USD 54,449
|
|
|
2011-03-10 |
2011-03-08 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
10,996
+0.2%
23.05
USD 253,503
|
10,996
+0.2%
|
23.05
|
USD 253,503
|
|
|
2011-03-10 |
2011-03-08 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
304
+0.2%
23.05
USD 7,008
|
304
+0.2%
|
23.05
|
USD 7,008
|
|
|
2011-03-09 |
2011-03-08 |
PS
Planned sale
|
ANIDO ARMANDO
CEO & President
Executive Director
|
5,275
-24.7%
23.03
USD 121,502
|
5,275
-24.7%
|
23.03
|
USD 121,502
|
|
|
2011-03-09 |
2011-03-08 |
PS
Planned sale
|
ANIDO ARMANDO
CEO & President
Executive Director
|
5,280
-24.7%
23.01
USD 121,492
|
5,280
-24.7%
|
23.01
|
USD 121,492
|
|
|
2011-01-12 |
2011-01-10 |
PS
Planned sale
|
ANIDO ARMANDO
CEO & President
Executive Director
|
5,275
-24.7%
23.27
USD 122,723
|
5,275
-24.7%
|
23.27
|
USD 122,723
|
|
|
2011-01-12 |
2011-01-10 |
PS
Planned sale
|
ANIDO ARMANDO
CEO & President
Executive Director
|
5,280
-24.7%
23.17
USD 122,327
|
5,280
-24.7%
|
23.17
|
USD 122,327
|
|
